BIOV — Biovaxys Technology Cashflow Statement
0.000.00%
Last trade - 00:00- CA$11.66m
- CA$11.57m
Annual cashflow statement for Biovaxys Technology, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.1 | -6.46 | -11.7 | -7.69 | -3.95 |
| Non-Cash Items | 0.325 | 1.25 | 8.23 | 4.44 | 2.04 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.449 | -0.083 | 1.93 | 2.19 | 0.054 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.23 | -5.29 | -1.57 | -1.05 | -1.86 |
| Capital Expenditures | — | — | — | — | -1.06 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.061 | 0 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.061 | 0 | — | — | -1.06 |
| Financing Cash Flow Items | 0 | -0.37 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.35 | 3.44 | 1.11 | 0.917 | 3.13 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.19 | -1.83 | -0.451 | -0.141 | 0.211 |